Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Mr. Morfeas Koumas

Morfeas Koumas, BSc, MSc

Ph.D. student

Morfeas is a neuroscientist and biologist who holds a BSc in Biological Sciences from the University of Cyprus and an MSc in Neuroscience for Drug Discovery from Aston University. He has recently joined our research team as a Ph.D. student to investigate the neurobiological underpinnings associated with opioid addiction and withdrawal.

His research focuses on exploring the potential efficacy of ketamine and its metabolites in reversing protracted opioid abstinence-induced maladaptive behavioral responses, employing rodent models. His research holds promise in identifying potential targets for therapeutic interventions aimed at mitigating the effects of opioid addiction.

During his Master’s training and undergraduate studies, Morfeas was involved in studies investigating the effects of catecholamines in the lateral entorhinal cortex using ex vivo electrophysiology, and the effects of ketamine’s metabolites on hippocampal synaptic plasticity during opioid withdrawal in mice.

Publications:

  • Onisiforou, A., Koumas, M., Michael, A., Zanos, P. Selective transcriptomic recovery by (2R,6R)-hydroxynorketamine in opioid-abstinent mice: Machine learning identifies predictive biomarkers. bioRxiv. 2025. https://doi.org/10.1101/2025.06.04.657935.
 
  • Michael, A.*, Onisiforou, A.*, Georgiou, P., Koumas, M., Powels, C., Mammadov, E., Georgiou A.N., Zanos, P. (2R,6R)-hydroxynorketamine prevents opioid abstinence-related negative affect and stress-induced reinstatement in mice. British Journal of Pharmacology, 2025, In Press. * Equal contribution. https://doi.org/10.1111/bph.70018.
 
  • Onisiforou, A., Michael, A., Apostolakis, M.,  Mammadov, E., Mitka, A., Kalatta, M.A., Koumas, M., Georgiou A., Chatzittofis, A., Panayiotou, G., Gergiou, P., Zarate, C.A., Zanos P. Ketamine and hydroxynorketamine as novel pharmacotherapies for the treatment of Opioid-Use Disorders. Biological Psychiatry. In Press. https://doi.org/10.1016/j.biopsych.2024.09.008
 
  • Michael, A.*, Onisiforou, A.*, Georgiou, P., Koumas, M., Mammadov, E., Zanos, P. (2R,6R)-hydroxynorketamine facilitates extinction and prevents emotional impairment and stress-induced reinstatement in morphine abstinent mice. bioRxiv (2023), 12.07.570550. * Equal Contribution. https://doi.org/10.1101/2023.12.07.570550.

Contact Info:

Email: koumas.morfeas@ucy.ac.cy

ORCID: https://orcid.org/0009-0004-3453-5334

Recent Posts

  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026
  • New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis February 24, 2026
  • New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms January 29, 2026
  • Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal January 17, 2026
  • Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine January 4, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress